Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis

Journal of Microbiology

Volumn 45, Issue 3, 2007, Pages 275-279

  Lambiase, Antonietta ^a   Raia, Valeria ^a   Stefani, Stefania ^b   Sepe, Angela ^a   Ferri, Pasqualina ^a   Buonpensiero, Paolo ^a   Rossano, Fabio ^a   Del Pezzo, Mariassunta ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Burkholderia cepacia complex; Cystic fibrosis; PFGE; Rec A gene

Indexed keywords

BACTERIAL DNA;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL GENE; BACTERIAL INFECTION; BURKHOLDERIA CEPACIA COMPLEX; CHILD; CLASSIFICATION; CYSTIC FIBROSIS; DNA FINGERPRINTING; EPIDEMIOLOGY; FEMALE; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; ITALY; MALE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS;

ADOLESCENT; ADULT; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; CHILD; CYSTIC FIBROSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENES, BACTERIAL; GENOTYPE; HUMANS; ITALY; MALE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE;

BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX;

EID: 34447134119     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Agodi, A., E. Mahenthiralingam, M. Barchitta, V. Gianninò, A. Sciacca, and S. Stefani. 2001. Burkholderia cepacia complex in fection in italian patients with cystic fibrosis: prevalence, epidemiology and genomovar status. J. Clin. Microbiol. 39, 2891-2896.
2. Allice, T., S. Scutera, M.G. Chirillo, and D. Savoia. 2006. Burkholderia respiratory tract infections in Italian patients with cystic fibrosis: molecular characterization. J. Infect. 53, 159-165.
3. Cystic Fibrosis Foundation. 2003. Patient Registry: Annual Data Report. Bethesda.
4. Coenye, T., P. Vandamme, J.R.W. Govan, and J.J. LiPuma. 2001. Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 39, 3427-3436.
5. Frederiksen, B., C. Koch, and N. Høiby. 1999. Changing epidemiology of Pseudomonas aeruginosa infection in Danish Cystic Fibrosis patients (1974-1995). Pediatr Pulmonol. 28, 159-166.
6. Gilligan, P.H. 1991. Microbiology of airway disease in patients with Cystic Fibrosis. Clin. Microbiol. Rev. 4, 35-51.
7. Goldstein, R., L. Sun, R.Z. Jiang, U. Sajjan, J. Forstner, and C. Campanelli. 1995. Structurally variant classes of pilus appendage fibers coexpressed from Burkholderia (Pseudomonas) cepacia. J. Bacteriol. 177, 1039-1052.
8. Grothues, D., U. Koopmann, H. Van der Hardt, and B. Tummler. 1988. Genome fingerprinting of Pseudomonas aeruginosa indicates colonization of cystic fibrosis siblings with closely related strains. J. Clin. Microbiol. 26, 115-123.
9. Lambiase, A., V. Raia, M. Del Pezzo, A. Sepe, V. Carnovale, and F. Rossano. 2006. Microbiology airway disease in a cohort of patients with cystic fibrosis. BMC Infect. Dis. 6, 4.
10. LiPuma, J.J. 1998. Burkholderia cepacia. Management issues and new insights. Clin. Chest Med. 19, 473-486.
11. LiPuma, J.J., T. Spilker, L.H. Gill, P.W. Campbell, L. Liu, and E. Mahenthiralingam. 2001. Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis. Am. J. Respir. Crit. Care Med. 164, 92-99.
12. Lipuma, J.J. 2005. Update on the Burkholderia cepacia complex. Curr. Opin. Pulm. Med. 11, 528-533.
13. Mahenthiralingam, E., D. Simpson, and D.P. Speert. 1997. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J. Clin. Microbiol. 35, 808-816.
14. Mahenthiralingam, E., J. Bischof, S.K. Byrne, C. Radomski, J.E. Davies, Y. Av-Gay, and P. Vandamme. 2000. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J. Clin. Microbiol. 38, 3165-3173.
15. Mahenthiralingam, E. and P. Vandamme. 2005. Taxonomy and pathogenesis of the Burkholderia cepacia complex. Chron. Respir. Dis. 2, 209-217.
16. Manno, G., C. Dalmastri, S. Tabacchioni, P. Vandamme, R. Lorini, L. Minicicci, L. Romano, A. Giannattasio, L. Chiarini, and A. Bevivino. 2004. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center. J. Clin. Microbiol. 42, 1491-1497.
17. McDowell, A., E. Mahenthiralingam, J.E. Moore, K.E.A. Dunbar, A.K. Webb, M.E. Dodd, S.L. Martin, B.C. Millar, C.J. Scott, M. Crowe, and J.S. Elborn. 2001. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J. Clin. Microbiol. 39, 4247-4255.
18. th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa, USA.
19. Saiman, L, N. MacDonald, J.L. Burns, N. Hoiby, D.P. Speert, and D. Weber. 2000. Infection control in cystic fibrosis: practical recommendations for the hospital, clinic, and social setting. Am. J. Infect. Control. 28, 381-385.
20. Saiman, L., N.E. MacDonald, and S. Whittier. 1996. The microbiological basis for antimicrobial therapy. In Tenth Annual North American Cystic Fibrosis Conference. Cystic Fibrosis Foundation. Orlando, USA.
21. Saiman, L. and J. Siegel. 2003. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens and infection control practices to prevent patient-to-patient transmission. Am. J. Infect. Control. 3 (Suppl).
22. Sajjan, U., L. Sun, R. Goldstein, and J. Forstner. 1995. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 177, 1030-1038.
23. Sun, L., R. Jiang, S. Steinbach, A. Holmes, C. Campanelli, J. Forstner, Y. Tan, M. Riley, and R. Goldstein. 1995. The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing Cystic Fibrosis centre epidemics in North America and Britan. Nat. Med. 1, 661-666.
24. Tablan, O.C., T.L. Chorba, D.V. Schidlow, J.W. White, K.A. Hardy, P.H. Gilligan, W.M. Morgan, L.A. Carson, W.J. Martone, J.M. Jason, and W.R. Jarvis. 1985. Pseudomonas cepacia colonization in patients with Cystic Fibrosis: risk factors and clinical outcome. J. Pediatr. 107, 382-387.
25. Tenover, F., R. Arbeit, R. Goering, P. Mickelsen, B. Murray, D. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233-2239.
26. Vandamme, P., D. Henry, T. Coenye, S. Nuzla, M. Vancanneyt, J.J. LiPuma, D.P. Speert, J.R.W. Govan, and E. Mahenthiralingam. 2002. Burkholderia anthina sp. nov. and Burkholderia pyrrocinia, two additional Burkholderia cepacia complex bacteria, may confound results of new molecular diagnostic tools. FEMS Immunol. Med. Microbiol. 33, 143-149.
27. Vermis, K., T. Coenye, J.J. LiPuma, E. Mahentheralingam, H.J. Nelis, and P. Vandamme. 2004. Proposal to accomodate Burkholderia cepacia genomovar VI as Burkholderia dolosa sp. nov. Int. J. Syst. Evol. Microbiol. 54, 689-691.